
1. Retrovirology. 2014 Nov 25;11:99. doi: 10.1186/s12977-014-0099-3.

HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of
viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.

Santos-Costa Q(1)(2)(3), Lopes MM(4), Calado M(5)(6)(7), Azevedo-Pereira
JM(8)(9)(10).

Author information: 
(1)Host-Pathogen Interaction Unit, Research Institute for Medicines and
Pharmaceutical Sciences (iMed.ULisboa), Faculdade de Farmácia, Universidade de
Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal. quirina.c@ff.ul.pt.
(2)Instituto de Medicina Molecular (IMM), Faculdade de Medicina, Universidade de 
Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal. quirina.c@ff.ul.pt.
(3)Centro de Patogénese Molecular, Unidade dos Retrovírus e Infecções Associadas 
(CPM-URIA), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 
1649-003, Lisboa, Portugal. quirina.c@ff.ul.pt.
(4)Centro de Patogénese Molecular, Unidade dos Retrovírus e Infecções Associadas 
(CPM-URIA), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 
1649-003, Lisboa, Portugal. mlopes@ff.ul.pt.
(5)Host-Pathogen Interaction Unit, Research Institute for Medicines and
Pharmaceutical Sciences (iMed.ULisboa), Faculdade de Farmácia, Universidade de
Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal. mrtcalado@ff.ul.pt.
(6)Instituto de Medicina Molecular (IMM), Faculdade de Medicina, Universidade de 
Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal. mrtcalado@ff.ul.pt.
(7)Centro de Patogénese Molecular, Unidade dos Retrovírus e Infecções Associadas 
(CPM-URIA), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 
1649-003, Lisboa, Portugal. mrtcalado@ff.ul.pt.
(8)Host-Pathogen Interaction Unit, Research Institute for Medicines and
Pharmaceutical Sciences (iMed.ULisboa), Faculdade de Farmácia, Universidade de
Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
miguel.pereira@ff.ul.pt.
(9)Instituto de Medicina Molecular (IMM), Faculdade de Medicina, Universidade de 
Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.
miguel.pereira@ff.ul.pt.
(10)Centro de Patogénese Molecular, Unidade dos Retrovírus e Infecções Associadas
(CPM-URIA), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 
1649-003, Lisboa, Portugal. miguel.pereira@ff.ul.pt.

BACKGROUND: Human immunodeficiency virus 1 and 2 (HIV-1 and HIV-2) use cellular
receptors in distinct ways. Besides a more promiscuous usage of coreceptors by
HIV-2 and a more frequent detection of CD4-independent HIV-2 isolates, we have
previously identified two HIV-2 isolates (HIV-2MIC97 and HIV-2MJC97) that do not 
use the two major HIV coreceptors: CCR5 and CXCR4. All these features suggest
that in HIV-2 the Env glycoprotein subunits may have a different structural
organization enabling distinct - although probably less efficient - interactions 
with cellular receptors.
RESULTS: By infectivity assays using GHOST cell line expressing CD4 and CCR8 and 
blocking experiments using CCR8-specific ligand, I-309, we show that efficient
replication of HIV-2MIC97 and HIV-2MJC97 requires the presence of CCR8 at plasma 
cell membrane. Additionally, we disclosed the determinants of chemokine receptor 
usage at the molecular level, and deciphered the amino acids involved in the
usage of CCR8 (R8 phenotype) and in the switch from CCR8 to CCR5 or to CCR5/CXCR4
usage (R5 or R5X4 phenotype). The data obtained from site-directed mutagenesis
clearly indicates that the main genetic determinants of coreceptor tropism are
located within the V1/V2 region of Env surface glycoprotein of these two viruses.
CONCLUSIONS: We conclude that a viral population able to use CCR8 and unable to
infect CCR5 or CXCR4-positive cells, may exist in some HIV-2 infected individuals
during an undefined time period, in the course of the asymptomatic stage of
infection. This suggests that in vivo alternate molecules might contribute to HIV
infection of natural target cells, at least under certain circumstances.
Furthermore we provide direct and unequivocal evidence that the usage of CCR8 and
the switch from R8 to R5 or R5X4 phenotype is determined by amino acids located
in the base and tip of V1 and V2 loops of HIV-2 Env surface glycoprotein.

DOI: 10.1186/s12977-014-0099-3 
PMCID: PMC4251929
PMID: 25421818  [Indexed for MEDLINE]

